Indeed, "tirzepatide led to substantial weight loss across all reproductive states," Castaneda said. "However, the ...

Eli Lilly & Co. failed to prove in a federal court that a business selling copycat versions of its obesity drug causes harm ...

Midlife weight gain is a persistent challenge for many women, but emerging research suggests hormone therapy may enhance response to glucagon-like peptide-1 (GLP-1)–based treatments.

Tirzepatide treatment may lead to OSA remission or mild nonsymptomatic OSA in patients with moderate to severe OSA and obesity.

GLP-1 medications such as Ozempic and Wegovy appear to make people feel less drunk and reduce alcohol cravings by delaying ...

But now, a scientific study has revealed the surprising way that weight loss and type 2 diabetes drugs could be helping you ...

Thousands of knockoff pens were confiscated by enforcement agents for the UK’s Medicines and Healthcare products Regulatory ...

Cipla and Eli Lilly India have announced an agreement to distribute a type 2 diabetes drug, tirzepatide, under the new brand ...

Eli Lilly (NYSE:LLY) has partnered with India's Cipla to market its weight-loss medication Tirzepatide under a new brand in the country. According to the agreement announced by the companies, Lilly ...

Semaglutide, tirzepatide, and other GLP-1 drugs appear to slow alcohol absorption and blunt its intoxicating effects, ...

Under the agreement, Cipla will market the drug under a new brand name, Yurpeak, while Lilly continues to sell it as Mounjaro ...

On Oct. 30, Eli Lilly will announce third-quarter earnings results that could lift the stock, or pressure it further. Here ...